vs
Northwest Natural Holding Co（NWN）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是Northwest Natural Holding Co的2.0倍（$772.1M vs $394.2M），Northwest Natural Holding Co同比增速更快（6.3% vs 5.9%），Revvity自由现金流更多（$161.8M vs $-131.0M），过去两年Revvity的营收复合增速更高（9.0% vs -4.6%）
西北天然气控股公司是美国上市公用事业企业，总部位于俄勒冈州波特兰，成立于1859年。核心业务为天然气配送，服务俄勒冈州西部、华盛顿州西南部的居民、商业及工业客户，同时运营水务业务，目前服务约80万用户，年营收超10亿美元。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
NWN vs RVTY — 直观对比
营收规模更大
RVTY
是对方的2.0倍
$394.2M
营收增速更快
NWN
高出0.4%
5.9%
自由现金流更多
RVTY
多$292.8M
$-131.0M
两年增速更快
RVTY
近两年复合增速
-4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $394.2M | $772.1M |
| 净利润 | — | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 28.4% | 14.5% |
| 净利率 | — | 12.7% |
| 营收同比 | 6.3% | 5.9% |
| 净利润同比 | — | 3.9% |
| 每股收益（稀释后） | $1.38 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NWNRVTY
| Q4 25 | $394.2M | $772.1M | ||
| Q3 25 | $164.7M | $698.9M | ||
| Q2 25 | $236.2M | $720.3M | ||
| Q1 25 | $494.3M | $664.8M | ||
| Q4 24 | $370.9M | $729.4M | ||
| Q3 24 | $136.9M | $684.0M | ||
| Q2 24 | $211.7M | $691.7M | ||
| Q1 24 | $433.5M | $649.9M |
净利润NWNRVTY
| Q4 25 | — | $98.4M | ||
| Q3 25 | $-29.9M | $46.7M | ||
| Q2 25 | $-2.5M | $53.9M | ||
| Q1 25 | $87.9M | $42.2M | ||
| Q4 24 | — | $94.6M | ||
| Q3 24 | $-27.2M | $94.4M | ||
| Q2 24 | $-2.8M | $55.4M | ||
| Q1 24 | $63.8M | $26.0M |
毛利率NWNRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率NWNRVTY
| Q4 25 | 28.4% | 14.5% | ||
| Q3 25 | -7.5% | 11.7% | ||
| Q2 25 | 11.5% | 12.6% | ||
| Q1 25 | 31.2% | 10.9% | ||
| Q4 24 | 22.9% | 16.3% | ||
| Q3 24 | -14.1% | 14.3% | ||
| Q2 24 | 7.4% | 12.4% | ||
| Q1 24 | 25.3% | 6.8% |
净利率NWNRVTY
| Q4 25 | — | 12.7% | ||
| Q3 25 | -18.1% | 6.7% | ||
| Q2 25 | -1.1% | 7.5% | ||
| Q1 25 | 17.8% | 6.4% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | -19.8% | 13.8% | ||
| Q2 24 | -1.3% | 8.0% | ||
| Q1 24 | 14.7% | 4.0% |
每股收益（稀释后）NWNRVTY
| Q4 25 | $1.38 | $0.86 | ||
| Q3 25 | $-0.73 | $0.40 | ||
| Q2 25 | $-0.06 | $0.46 | ||
| Q1 25 | $2.18 | $0.35 | ||
| Q4 24 | $1.12 | $0.77 | ||
| Q3 24 | $-0.71 | $0.77 | ||
| Q2 24 | $-0.07 | $0.45 | ||
| Q1 24 | $1.69 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $36.7M | $919.9M |
| 总债务越低越好 | $2.4B | — |
| 股东权益账面价值 | $1.5B | $7.3B |
| 总资产 | $6.2B | $12.2B |
| 负债/权益比越低杠杆越低 | 1.65× | — |
8季度趋势，按日历期对齐
现金及短期投资NWNRVTY
| Q4 25 | $36.7M | $919.9M | ||
| Q3 25 | $32.2M | $931.4M | ||
| Q2 25 | $102.6M | $991.8M | ||
| Q1 25 | $100.0M | $1.1B | ||
| Q4 24 | $38.5M | $1.2B | ||
| Q3 24 | $35.0M | $1.2B | ||
| Q2 24 | $65.2M | $2.0B | ||
| Q1 24 | $72.4M | $1.7B |
总债务NWNRVTY
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.6B | — |
股东权益NWNRVTY
| Q4 25 | $1.5B | $7.3B | ||
| Q3 25 | $1.4B | $7.4B | ||
| Q2 25 | $1.5B | $7.6B | ||
| Q1 25 | $1.5B | $7.6B | ||
| Q4 24 | $1.4B | $7.7B | ||
| Q3 24 | $1.4B | $7.9B | ||
| Q2 24 | $1.3B | $7.9B | ||
| Q1 24 | $1.3B | $7.8B |
总资产NWNRVTY
| Q4 25 | $6.2B | $12.2B | ||
| Q3 25 | $5.9B | $12.1B | ||
| Q2 25 | $5.8B | $12.4B | ||
| Q1 25 | $5.7B | $12.4B | ||
| Q4 24 | $5.2B | $12.4B | ||
| Q3 24 | $4.9B | $12.8B | ||
| Q2 24 | $4.8B | $13.4B | ||
| Q1 24 | $4.8B | $13.4B |
负债/权益比NWNRVTY
| Q4 25 | 1.65× | — | ||
| Q3 25 | 1.56× | — | ||
| Q2 25 | 1.53× | — | ||
| Q1 25 | 1.53× | — | ||
| Q4 24 | 1.23× | — | ||
| Q3 24 | 1.16× | — | ||
| Q2 24 | 1.17× | — | ||
| Q1 24 | 1.17× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.3M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $-131.0M | $161.8M |
| 自由现金流率自由现金流/营收 | -33.2% | 21.0% |
| 资本支出强度资本支出/营收 | 34.1% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | $-197.8M | $509.4M |
8季度趋势，按日历期对齐
经营现金流NWNRVTY
| Q4 25 | $3.3M | $182.0M | ||
| Q3 25 | $-15.9M | $138.5M | ||
| Q2 25 | $102.2M | $134.3M | ||
| Q1 25 | $179.6M | $128.2M | ||
| Q4 24 | $-19.4M | $174.2M | ||
| Q3 24 | $-26.4M | $147.9M | ||
| Q2 24 | $121.0M | $158.6M | ||
| Q1 24 | $125.0M | $147.6M |
自由现金流NWNRVTY
| Q4 25 | $-131.0M | $161.8M | ||
| Q3 25 | $-125.9M | $120.0M | ||
| Q2 25 | $-18.3M | $115.5M | ||
| Q1 25 | $77.4M | $112.2M | ||
| Q4 24 | $-119.6M | $149.8M | ||
| Q3 24 | $-121.7M | $125.6M | ||
| Q2 24 | $4.3M | $136.6M | ||
| Q1 24 | $42.8M | $129.7M |
自由现金流率NWNRVTY
| Q4 25 | -33.2% | 21.0% | ||
| Q3 25 | -76.4% | 17.2% | ||
| Q2 25 | -7.8% | 16.0% | ||
| Q1 25 | 15.7% | 16.9% | ||
| Q4 24 | -32.2% | 20.5% | ||
| Q3 24 | -88.9% | 18.4% | ||
| Q2 24 | 2.0% | 19.7% | ||
| Q1 24 | 9.9% | 20.0% |
资本支出强度NWNRVTY
| Q4 25 | 34.1% | 2.6% | ||
| Q3 25 | 66.8% | 2.6% | ||
| Q2 25 | 51.0% | 2.6% | ||
| Q1 25 | 20.7% | 2.4% | ||
| Q4 24 | 27.0% | 3.4% | ||
| Q3 24 | 69.6% | 3.3% | ||
| Q2 24 | 55.1% | 3.2% | ||
| Q1 24 | 19.0% | 2.7% |
现金转化率NWNRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | 2.04× | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | 1.96× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NWN
| NWN Gas Utility | $341.4M | 87% |
| Alternativerevenue | $27.2M | 7% |
| Si Energy Gas Utility | $20.0M | 5% |
| NW Natural Other | $6.9M | 2% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
